Meta-analysis: Liquid cinnamon extract helps control blood-sugar levels
TUSTIN, Calif. — A new meta-analysis released Wednesday of eight clinical trials examining the effect of cinnamon consumption in people with Type 2 diabetes and/or prediabetes concluded cinnamon extract and/or cinnamon helps lower blood-glucose levels. The analysis was published in the Journal of Medicinal Foods.
When isolating those studies using only cinnamon extract, researchers found that "a significant overall effect on blood-glucose levels" was retained. "Consuming cinnamon, especially cinnamon extract, does produce a modest but statistically significant lowering in fasting blood glucose," said Paul Davis of the Department of Nutrition, University of California. "Using water extracts of cinnamon achieves the desired blood glucose effects while avoiding the nonpolar constituents in whole cinnamon or the cinnamon flavor components that have been linked to deleterious effects (e.g., oral lesions and mutagenicity)," he added.
Aqueous cinnamon extraction, which uses only cinnamon, water, heat and pressure, creates concentrated levels of specific procyanidins believed to be the active ingredients in promoting healthy glucose levels.
APAP suppository FeverAll returns to store shelves
MORRISTOWN, N.J. — Actavis is in the process of bringing FeverAll acetaminophen suppositories back to the market, the company announced. FeverAll had been unavailable while changes were being made at the product’s manufacturing facility.
According to the company, FeverAll is the only infant-strength acetaminophen suppository available for sale over-the-counter. The suppository dose form has two advantages. First, suppositories help reassure parents that their child is getting the full dose of the medicine. Second, parents may also prefer FeverAll when fever or pain is accompanied by an upset stomach, or when their child has difficulty swallowing. "Because it is a suppository, there are no worries about a child spitting it out, like with liquid medications," said Sarita Thapar, Actavis director of medical affairs. "As a mom, that’s one less thing to worry about when your little one isn’t feeling well."
The brand and Thapar were featured on a segment of Lifetime Television’s "The Balancing Act." To view that video go to FeverAll.com.
Packaged Facts: Pet drug sales to reach $6.7 billion in 2011
NEW YORK — While sales figures for pharmaceuticals are frequently reported on, drugs for people’s four-legged friends also are a money maker.
According to Packaged Facts, a division of MarketResearch.com, retail sales of pet medications — including sales through retail stores, online retailers and veterinarians — will reach $6.7 billion this year.
A new report from the firm, "Pet Medications in the U.S.," mass market channels are the least involved in pet medications among retailers. But online pharmacies, including those of Target and Walmart, have expanded their product range. Currently, according to the firm’s May-June 2011 Pet Owner Survey, 71% of prescription-only heartworm medications and 40% of nonprescription flea and tick spot-ons continue to be sold through veterinarians, which for many years "have been in the catbird seat" in pet medication sales.
"The underpinnings of the U.S. pet industry remain strong, and the outlook is especially favorable for all things pet-related," Packaged Facts publisher David Sprinkle said.
In some ways, trends driving pet medications seem to mirror the ones driving human medications. "Taking into account market drivers including the aging pet population, pet obesity and the heavy involvement of major pharmaceuticals companies, pet medications sales should return to their pre-recession rates of growth over the next few years, with annual percentage gains projected at 10% by 2015."